Dr. Douglas Weckstein, MD
Claim this profileSolinsky Center for Cancer Care
About Douglas Weckstein, MD
Education:
Earned an MD (Doctor of Medicine).
Experience:
Serves as Principal Investigator for the PREDICT-RT Trial at Solinsky Center for Cancer Care.
Area of expertise
Lung Cancer
Douglas Weckstein, MD has run 17 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Douglas Weckstein, MD has run 14 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
Solinsky Center For Cancer Care
New Hampshire Oncology Hematology PA-Concord
Clinical Trials Douglas Weckstein, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
More about Douglas Weckstein, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 53 trials as a Principal Investigator · 18 Active Clinical Trials
Treatments Douglas Weckstein, MD has experience with
- Pembrolizumab
- Carboplatin
- Paclitaxel
- Nivolumab
- Atezolizumab
- Radiation Therapy
Breakdown of trials Douglas Weckstein, MD has run
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Douglas Weckstein, MD specialize in?
Douglas Weckstein, MD focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Douglas Weckstein, MD currently recruiting for clinical trials?
Yes, Douglas Weckstein, MD is currently recruiting for 18 clinical trials in Manchester New Hampshire. If you're interested in participating, you should apply.
Are there any treatments that Douglas Weckstein, MD has studied deeply?
Yes, Douglas Weckstein, MD has studied treatments such as Pembrolizumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Douglas Weckstein, MD?
Apply for one of the trials that Douglas Weckstein, MD is conducting.
What is the office address of Douglas Weckstein, MD?
The office of Douglas Weckstein, MD is located at: Solinsky Center for Cancer Care, Manchester, New Hampshire 03103 United States. This is the address for their practice at the Solinsky Center for Cancer Care.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.